Dave Eherts, Vice President of EHS; Allergan plc
Dr. Eherts joined Allergan (then Actavis) Pharmaceuticals in March of 2014 as Vice President of Global EHS. Allergan plc, headquartered in Dublin, Ireland, is a global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories.
Prior to Allergan, David has worked over 35 years in the fields of Safety and EHS starting as a toxicologist in Pre-Clinical Drug Safety Assessment at Merck. He moved to EHS and has held positions of increasing responsibility at Merck, sanofi-aventis, Purdue Pharmaceuticals and most recently, he served as Chief Safety Officer and Vice President of EHS, Medical, Security, Aviation and Product Safety at Sikorsky Aircraft. His experience and expertise span environmental toxicology, occupational health, potent compound control, aviation safety and management systems in the aerospace, healthcare and pharmaceutical industries. Dave holds Bachelor's degrees in Chemistry and Biology and a Masters and PhD in Environmental Toxicology from Drexel University. David was recently appointed by the US Secretary of Labor to the Federal Whistleblower Protection Advisory Committee. He also serves on the advisory board for ORCHSE, on their New View of Safety Taskforce and has served on the board of directors for Occupational Knowledge International (an NGO dedicated to preventing overexposures to toxic chemicals in developing countries) and SoundWaters (an NGO dedicated to preserving Long Island Sound). In his spare time, he's a Sunday School Teacher and an adjunct professor at New York Medical College and at Tulane University where he teaches courses in EHS Management, Environmental Toxicology, Finance, Industrial Hygiene and Occupational Health.